Suraksha Diagnostic Limited is set to launch its Initial Public Offering (IPO), providing an opportunity for investors interested in the healthcare diagnostics sector. The IPO has garnered attention for its significant issue size and its role in expanding the company’s market presence. Here is a comprehensive overview of the Suraksha Diagnostic IPO GMP today, Business Overview, Financials, Review, and FAQ’s.
Suraksha Diagnostic IPO Details
The Suraksha Diagnostic IPO is slated to open on November 29, 2024, and close on December 3, 2024. The company aims to raise approximately ₹846.25 crore through an Offer for Sale (OFS) of up to 19,189,330 equity shares. The IPO has a price band set between ₹420 and ₹441 per share. Investors can apply for a minimum lot size of 34 shares, which requires an investment of approximately ₹14,994. The IPO will list on BSE and NSE.
Key IPO Dates and Details
| Event | Date |
|---|---|
| Opening Date | November 29, 2024 |
| Closing Date | December 3, 2024 |
| Anchor Investor Bidding | November 28, 2024 |
| Allotment Finalization | December 4, 2024 |
| Credit of Shares | December 5, 2024 |
| Listing Date | December 6, 2024 |
Subscription Details
The IPO allocation is divided as follows:
- Qualified Institutional Buyers (QIBs): 50%
- Non-Institutional Investors (NIIs): 15%
- Retail Investors: 35%
Retail investors can apply for a minimum of one lot (34 shares), amounting to approximately ₹14,994 at the upper price band. The allocation for QIBs and NIIs ensures balanced participation from different investor categories.
Suraksha Diagnostic IPO GMP Today
Suraksha Diagnostic IPO GMP Today is reported to be zero. This indicates that shares are expected to list at par with the issue price, reflecting cautious market sentiment. The Suraksha Diagnostic IPO GMP provides a glimpse into the potential listing gains or losses but should not be the sole factor for investment decisions.
Suraksha Diagnostic Business Overview
Established in 1992 and incorporated in 2005, Suraksha Diagnostic Limited is a leading diagnostic service provider in Eastern India. The company specializes in pathology and radiology services, offering over 2,300 diagnostic tests. It operates an extensive network of:
- 1 Central Reference Laboratory
- 8 Satellite Laboratories
- 49 Diagnostic Centres
- 166 Sample Collection Centres
Suraksha Diagnostic has a robust presence in states like West Bengal, Bihar, Assam, and Meghalaya, catering to diverse healthcare needs with its accessible and efficient diagnostic solutions.
Core Services
- Pathology: Routine and specialized tests, including molecular pathology.
- Radiology: Advanced imaging services such as MRIs and X-rays.
- Medical Consultations: Available through associated polyclinics.
The company leverages state-of-the-art technology from global manufacturers like GE and Siemens and uses advanced management systems such as Laboratory Information Management Systems (LIMS) and Radiology Information Systems (RIS).
Suraksha Diagnostic Limited Financials
Suraksha Diagnostic has shown impressive financial growth in recent years. Below is a summary of its key financial metrics:
| Period | Revenue (₹ Cr) | Profit After Tax (₹ Cr) | Total Assets (₹ Cr) | Net Worth (₹ Cr) |
|---|---|---|---|---|
| FY 2022 | 225.77 | 20.82 | 275.96 | 145.84 |
| FY 2023 | 193.69 | 6.07 | 281.20 | 155.93 |
| FY 2024 | 222.26 | 23.13 | 300.21 | 179.41 |
| Q1 FY 2025 | 61.85 | 7.67 | 314.20 | 187.05 |
Financial Highlights
- Revenue Growth: From ₹193.69 crore in FY 2023 to ₹222.26 crore in FY 2024, a growth of 14.75%.
- Profit Surge: Profit after tax jumped significantly from ₹6.07 crore in FY 2023 to ₹23.13 crore in FY 2024.
- Resilience in Assets and Net Worth: Total assets grew to ₹300.21 crore in FY 2024, and net worth improved to ₹179.41 crore.
Suraksha Diagnostic IPO Review
Suraksha Diagnostic’s financial trajectory demonstrates strong growth and resilience. The company’s consistent revenue and profit growth highlight its operational efficiency and market relevance. Its established network in Eastern India and focus on expanding into Northeastern markets position it as a key player in the healthcare diagnostics sector.
Suraksha Diagnostic IPO Allotment
The IPO allotment is expected to be finalized on December 4, 2024, with refunds initiated on the same day for unsuccessful applicants. The shares will be credited to demat accounts on December 5, 2024, and listing is scheduled for December 6, 2024.
Allotment Summary
| Event | Date |
|---|---|
| Allotment Finalization | December 4, 2024 |
| Refund Initiation | December 4, 2024 |
| Demat Credit | December 5, 2024 |
| Listing | December 6, 2024 |
FAQs
What is the Suraksha Diagnostic IPO?
The Suraksha Diagnostic IPO is an Offer for Sale (OFS) aiming to raise ₹846.25 crore through the sale of 19,189,330 equity shares at a price band of ₹420-₹441 per share.
When will the IPO open and close?
The IPO will open on November 29, 2024, and close on December 3, 2024.
What is the Suraksha Diagnostic IPO GMP Today?
Suraksha Diagnostic IPO GMP Today is reported to be zero.
What is the minimum investment required?
Retail investors must invest a minimum of ₹14,994 for one lot (34 shares).
When will the shares be listed?
The shares are expected to list on December 6, 2024, on BSE and NSE.
Suraksha Diagnostic Limited’s IPO provides a robust investment opportunity in the growing diagnostics sector, backed by strong financials and market presence. However, investors should evaluate risks and consider market conditions before investing.
